
Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
Blood Cancer Talks
00:00
The Role of Beer Cop in the Treatment of Solid Tumors
The next trial we came to hear your thoughts on is HD21 which is run by the German Hodgkin study group and that was a phase 3 trial of about 1500 patients where they could pet adapted breakad versus escalated beer cop. And depending on whether patients had a positive or negative interimpette scan they would either receive four cycles or six cycles of whichever arm they were randomized to. The three year PFS was 94.9% with breakad and 92.3% for escalated beer cop which demonstrated non inferiority and also showed a trend towards superiority. So yeah were there any other comments you wanted to add about 1826 before we swap to break hand? No I don't think so
Transcript
Play full episode